mosapride has been researched along with Arrhythmia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, K; Lee, H; Lee, YC; Min, YW; Rhee, PL; Son, HJ; Song, BG | 1 |
| Kawatsu, R; Kohmura, Y; Toga, T | 1 |
| Amos, GJ; Andersson, B; Carlsson, L; Drews, L; Duker, G; Wadstedt, G | 1 |
| Baró, I; Bouyssou, T; Escande, D; Potet, F | 1 |
4 other study(ies) available for mosapride and Arrhythmia
| Article | Year |
|---|---|
Risk of domperidone induced severe ventricular arrhythmia.
Topics: Adolescent; Adult; Aged; Antiemetics; Arrhythmias, Cardiac; Benzamides; Benzyl Compounds; Child; Child, Preschool; Databases, Factual; Domperidone; Female; Humans; Incidence; Infant; Infant, Newborn; Male; Middle Aged; Morpholines; Risk Factors; Severity of Illness Index; Young Adult | 2020 |
The 5-HT(4) agonists cisapride, mosapride, and CJ-033466, a Novel potent compound, exhibit different human ether-a-go-go-related gene (hERG)-blocking activities.
Topics: Aminopyridines; Arrhythmias, Cardiac; Benzamides; Cell Line; Cisapride; Electrophysiology; Ether-A-Go-Go Potassium Channels; Humans; Imidazoles; Inhibitory Concentration 50; Morpholines; Patch-Clamp Techniques; Serotonin 5-HT4 Receptor Agonists; Serotonin Receptor Agonists | 2007 |
Electrophysiological characterization of the prokinetic agents cisapride and mosapride in vivo and in vitro: implications for proarrhythmic potential?
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Benzamides; Cisapride; Guinea Pigs; Heart; In Vitro Techniques; Long QT Syndrome; Male; Morpholines; Piperidines; Purkinje Fibers; Rabbits; Structure-Activity Relationship | 1997 |
Gastrointestinal prokinetic drugs have different affinity for the human cardiac human ether-à-gogo K(+) channel.
Topics: Animals; Arrhythmias, Cardiac; Benzamides; Benzofurans; Bridged Bicyclo Compounds, Heterocyclic; Cation Transport Proteins; Cisapride; DNA-Binding Proteins; Electrophysiology; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Gastrointestinal Agents; Glycosaminoglycans; Humans; Morpholines; Potassium Channels; Potassium Channels, Voltage-Gated; Recombinant Proteins; Serotonin Antagonists; Trans-Activators; Transcriptional Regulator ERG | 2001 |